Obesity Drugs Could Get Lift From Part D Legislation, AMA Policy
This article was originally published in The Pink Sheet Daily
Executive Summary
Two events lead the way to greater coverage and reimbursement for obesity drugs: a bipartisan, bicameral bill that would remove Medicare Part D’s ban on covering obesity drugs and AMA’s recognition of obesity as a disease.